GO:0015797 mannitol transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015797 (mannitol transmembrane transport) describes the directed movement of mannitol, the alditol derived from D-mannose, across a biological membrane.
• The best-characterized mannitol transport system is the mannitol-specific phosphoenolpyruvate-dependent phosphotransferase system (PTS) in Escherichia coli, encoded by the mtlA gene.
• The mannitol transporter Enzyme IIMtl couples mannitol translocation to phosphorylation via a structural domain that interacts with the phosphocarrier protein HPr.
• Mannitol transport is relevant to human health because mannitol is used as an osmotic agent to hydrate airway mucus in cystic fibrosis and to modulate the blood-cerebrospinal fluid barrier.
• Studying mannitol transmembrane transport requires membrane protein biochemistry, structural biology, and genetic knockout or point-mutation models.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate mannitol transport genes in bacterial and mammalian systems.
Description
Mannitol transmembrane transport (GO:0015797) is the biological process by which mannitol, a six-carbon sugar alcohol derived from D-mannose by reduction of the aldehyde group, is moved across a membrane. This process is essential for mannitol utilization in bacteria and for mannitol-based osmotic therapies in human medicine. The mannitol-specific phosphoenolpyruvate-dependent phosphotransferase system (PTS) of Escherichia coli is the archetypal system for studying this transport event, because it couples mannitol uptake to phosphorylation through a well-defined structural domain. Researchers study GO:0015797 to understand membrane transport mechanics, to engineer mannitol-producing or mannitol-consuming strains, and to optimize mannitol-based clinical interventions such as airway surface hydration in cystic fibrosis. The process is also relevant to the blood-cerebrospinal fluid barrier, where osmolarity and solute movement influence central nervous system homeostasis. Because mannitol transport is a membrane-embedded event, its investigation requires specialized tools including membrane protein purification, structural determination, and genetic manipulation of transporter genes.
mannitol transmembrane transport At A Glance
| GO ID | GO:0015797 |
|---|---|
| GO term | mannitol transmembrane transport |
| Ontology | biological_process |
| Synonym | mannitol transport |
| Definition | The directed movement of mannitol across a membrane. Mannitol is the alditol derived from D-mannose by reduction of the aldehyde group. |
| Major function | Translocation of mannitol across biological membranes, often coupled to phosphorylation in bacterial PTS systems. |
| Key transporter | Mannitol-specific Enzyme IIMtl (mtlA) in Escherichia coli. |
| Structural feature | A transmembrane domain and a phosphorylation-coupled domain that interacts with HPr. |
| Clinical relevance | Mannitol is used as an osmotic agent for airway mucus hydration in cystic fibrosis and for blood-cerebrospinal fluid barrier studies. |
What Is GO:0015797?
GO:0015797, mannitol transmembrane transport, is defined as the directed movement of mannitol across a membrane. Mannitol is the alditol derived from D-mannose by reduction of the aldehyde group. This process encompasses the translocation of mannitol from one side of a lipid bilayer to the other, often mediated by dedicated transport proteins such as the mannitol-specific Enzyme IIMtl of the bacterial phosphotransferase system.
Why Is mannitol transmembrane transport Important in Cell Biology?
Mannitol transmembrane transport is important because it controls the cellular and extracellular distribution of a clinically used osmolyte and a carbon source for bacteria. In cystic fibrosis, inhaled mannitol is used to hydrate airway mucus and improve mucociliary clearance, and its efficacy depends on mannitol movement across epithelial membranes. In neurobiology, mannitol transport contributes to osmotic regulation at the blood-cerebrospinal fluid barrier, which is critical for brain homeostasis. In microbiology, the mannitol-specific PTS is a paradigm for understanding how transport is coupled to phosphorylation and how bacteria prioritize carbon sources. Understanding GO:0015797 therefore bridges membrane biochemistry, infectious disease, and human therapeutics.
• Mannitol is a clinically approved osmotic agent for hydrating airway mucus in cystic fibrosis.
• Mannitol transport at the blood-cerebrospinal fluid barrier influences central nervous system fluid balance.
• The mannitol-specific PTS in Escherichia coli is a model system for studying transport-phosphorylation coupling.
• Mannitol uptake is a determinant of bacterial carbon source utilization and competitiveness.
• Mannitol transport proteins are targets for structural biology of membrane transporters.
• Defects or alterations in mannitol transport can affect osmolarity and cell volume regulation.
• Mannitol is used as a pharmaceutical excipient and osmotic diuretic, making its transport pharmacologically relevant.
• Understanding mannitol transport supports metabolic engineering of mannitol production.
• Mannitol transport is a potential target for antimicrobial strategies against PTS-dependent pathogens.
• Research on GO:0015797 informs the design of mannitol-based therapies for respiratory and neurological conditions.
What Happens During mannitol transmembrane transport?
Substrate recognition and binding
In simple terms: The transporter first grabs mannitol on one side of the membrane.
In the mannitol-specific phosphotransferase system of Escherichia coli, the membrane-bound Enzyme IIMtl recognizes mannitol and binds it at a site within the transmembrane domain. This initial binding is the first committed step of the transport cycle and determines substrate specificity.
Phosphorylation-coupled translocation
In simple terms: The transporter chemically tags mannitol with a phosphate as it moves it across the membrane.
The mannitol-specific transport protein couples mannitol translocation to phosphorylation. A structural and functional domain of the transporter is involved in coupling mannitol transport and phosphorylation in the phosphoenolpyruvate-dependent phosphotransferase system. This coupling ensures that mannitol is phosphorylated as it enters the cell, trapping it inside.
Interaction with phosphocarrier proteins
In simple terms: The transporter receives phosphate groups from other proteins in a relay chain.
The phosphorylation of mannitol during transport depends on a phosphorelay involving the phosphocarrier protein HPr and other PTS components. The mannitol-specific Enzyme IIMtl interacts with these phosphocarrier proteins to receive phosphate groups that are ultimately transferred to mannitol.
Membrane domain dynamics
In simple terms: The part of the transporter inside the membrane changes shape to let mannitol through.
The transmembrane domain of the mannitol transporter Enzyme II has been structurally characterized. The 5 A projection structure of the transmembrane domain of the mannitol transporter enzyme II reveals the architecture of the membrane-embedded portion that forms the translocation pathway. These structural dynamics are essential for moving mannitol across the lipid bilayer.
Release of mannitol phosphate into the cytoplasm
In simple terms: Once inside, the modified mannitol is released for use by the cell.
After translocation and phosphorylation, mannitol is released into the cytoplasm as mannitol-1-phosphate, which can then enter metabolic pathways. This release step completes the transport cycle and allows the cell to utilize mannitol as a carbon source.
Key Genes Involved in GO:0015797 mannitol transmembrane transport
The following genes and proteins are directly implicated in mannitol transmembrane transport or in the clinical and experimental contexts where mannitol movement across membranes is studied.
| Gene | Major Role | Research Relevance |
|---|---|---|
| mtlA (E. coli) | Encodes the mannitol-specific Enzyme IIMtl transporter | Model for transport-phosphorylation coupling in PTS |
| ptsH (E. coli) | Encodes the phosphocarrier protein HPr | Provides phosphate groups to Enzyme IIMtl during mannitol transport |
| ptsI (E. coli) | Encodes Enzyme I of the PTS | Initiates the phosphorelay that drives mannitol phosphorylation |
| mtlD (E. coli) | Mannitol-1-phosphate dehydrogenase | Metabolizes the product of mannitol transport |
| CFTR (human) | Chloride channel mutated in cystic fibrosis | Context for mannitol-based airway hydration therapies |
| MUC5AC (human) | Airway mucin | Target of mannitol-induced mucus hydration |
| MUC5B (human) | Airway mucin | Target of mannitol-induced mucus hydration |
| AQP1 (human) | Aquaporin water channel | Contributes to osmotic water movement following mannitol transport |
| AQP4 (human) | Aquaporin water channel | Involved in brain water homeostasis at the blood-CSF barrier |
| SLC2A1 (human) | Glucose transporter GLUT1 | Comparative model for transmembrane sugar alcohol transport |
| SLC2A4 (human) | Insulin-responsive glucose transporter | Comparative model for regulated transmembrane transport |
| SLC5A1 (human) | Sodium-glucose cotransporter | Comparative model for solute-coupled transport |
| TJP1 (human) | Tight junction protein ZO-1 | Maintains barrier integrity at the blood-CSF barrier |
| CLDN5 (human) | Claudin-5 | Tight junction component influencing paracellular mannitol movement |
| OCLN (human) | Occludin | Tight junction protein affecting barrier permeability |
| DNASE1 (human) | Dornase alfa target | Used with mannitol in cystic fibrosis airway clearance |
| SCNN1A (human) | Epithelial sodium channel subunit | Regulates airway surface liquid volume |
How Is mannitol transmembrane transport Regulated?
Mannitol transmembrane transport is regulated at multiple levels. In bacteria, the mannitol-specific PTS is controlled by carbon catabolite repression and by the availability of phosphoenolpyruvate, which drives the phosphorelay. The phosphorylation state of Enzyme IIMtl determines whether mannitol is transported and phosphorylated. In human airways, mannitol transport and its osmotic effects are influenced by the composition of the airway surface liquid and by mucin hydration status. At the blood-cerebrospinal fluid barrier, mannitol movement is affected by tight junction integrity and by aquaporin-mediated water flux. Therapeutic modulation of mannitol transport is achieved clinically by administering inhaled mannitol to hydrate mucus in cystic fibrosis.
mannitol transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CFTR | Cystic fibrosis | CFTR knockout or point-mutation airway epithelial cells |
| MUC5AC | Airway mucus obstruction | MUC5AC overexpression or knockout in airway cells |
| AQP1 | Cerebrospinal fluid homeostasis | AQP1 knockout mouse or cell model |
| mtlA | Bacterial mannitol utilization | mtlA knockout E. coli |
| CLDN5 | Blood-CSF barrier permeability | CLDN5 knockdown or knockout endothelial cells |
Cystic fibrosis and airway mucus hydration
In cystic fibrosis, defective CFTR function leads to dehydrated airway mucus and impaired mucociliary clearance. Inhaled mannitol is used as an osmotic agent to hydrate the airway surface and improve mucus clearance. The therapeutic effect depends on mannitol movement across the airway epithelium and the resulting osmotic water flow. Dornase alfa is often used in combination with osmotic therapies to reduce mucus viscosity.
Blood-cerebrospinal fluid barrier and neurological disease
The blood-cerebrospinal fluid barrier regulates the composition of cerebrospinal fluid and protects the brain. Mannitol is used experimentally and clinically to modulate osmotic gradients at this barrier. Alterations in barrier integrity, including tight junction protein expression, can affect mannitol permeability and central nervous system drug delivery. Aquaporins contribute to water movement that follows mannitol transport.
Bacterial pathogenesis and metabolic engineering
The mannitol-specific PTS is a key determinant of mannitol utilization in Escherichia coli and related bacteria. Understanding this transport system informs strategies to engineer mannitol production or to target PTS-dependent pathogens. Structural studies of the mannitol transporter provide a basis for designing inhibitors or improved transporters.
From mannitol transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does mtlA mediate mannitol transport? | mtlA knockout E. coli |
| How does phosphorylation couple to transport? | Point mutations in mtlA phosphoacceptor domain |
| What is the structure of the mannitol transporter? | Purified Enzyme IIMtl for cryo-EM or crystallography |
| Does mannitol hydrate airway mucus? | CFTR mutant airway epithelial cells treated with mannitol |
| Does mannitol cross the blood-CSF barrier? | In vitro blood-CSF barrier models with tight junction proteins |
| Can mannitol transport be engineered? | Overexpression of mtlA in heterologous hosts |
How to Study the mannitol transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled mannitol uptake | Rate of mannitol transport | Bacterial PTS assays |
| Proteoliposome reconstitution | Transport activity of purified transporter | Enzyme IIMtl function |
| Electron crystallography | Projection structure of transmembrane domain | Mannitol transporter architecture |
| CRISPR knockout | Loss of transport function | mtlA gene essentiality |
| Site-directed mutagenesis | Phosphorylation-coupled transport | Domain mapping of Enzyme IIMtl |
| Lung clearance index | Mucus clearance in cystic fibrosis | Mannitol therapy trials |
| Tracer permeability assays | Blood-CSF barrier permeability | Mannitol osmotic studies |
| RNA-seq | Expression of transport and mucin genes | Airway epithelial responses to mannitol |
Membrane protein biochemistry and transport assays
Transport assays using radiolabeled mannitol or fluorescent analogs measure the rate and direction of mannitol movement across membranes. Purification of the mannitol-specific Enzyme IIMtl allows reconstitution into proteoliposomes for controlled transport studies. These assays are essential for determining kinetic parameters and substrate specificity.
Structural biology of transporters
Electron crystallography and cryo-electron microscopy have been used to determine the projection structure of the transmembrane domain of the mannitol transporter Enzyme II. Structural information reveals the translocation pathway and conformational changes during transport. Complementary techniques include nuclear magnetic resonance and molecular dynamics simulations.
Genetic and CRISPR-based perturbation
Knockout of mtlA in Escherichia coli abolishes mannitol transport and utilization, providing a clean genetic test of function. Point mutations in the phosphorylation domain can separate transport from phosphorylation. CRISPR-based knock-in of tagged transporters enables localization and interaction studies.
Clinical and physiological measurements
In cystic fibrosis research, mannitol is administered as an inhaled osmotic agent and its effects on mucus clearance are measured by lung clearance index and other pulmonary function tests. At the blood-cerebrospinal fluid barrier, mannitol permeability is assessed using in vitro barrier models and tracer studies. These methods link molecular transport to clinical outcomes.
How CRISPR Can Be Used to Study GO:0015797 mannitol transmembrane transport
Knockout
CRISPR knockout of mtlA in Escherichia coli eliminates mannitol transport and growth on mannitol as a sole carbon source, providing definitive evidence of gene function. In human airway cells, knockout of CFTR or mucin genes can model the cystic fibrosis phenotype and test mannitol responses.
Point Mutation
Point mutations in the phosphoacceptor domain of mtlA can uncouple mannitol transport from phosphorylation, allowing dissection of the transport cycle. CRISPR-based point mutation in CFTR can recreate patient-specific cystic fibrosis mutations for drug testing.
Knock-in
Knock-in of epitope-tagged mtlA enables localization and interaction studies of the mannitol transporter in its native membrane environment. Knock-in of fluorescent tags in aquaporin genes can track water flux following mannitol transport.
Overexpression
Overexpression of mtlA in heterologous hosts increases mannitol transport capacity and can be used for metabolic engineering of mannitol utilization or production. Overexpression of mucins in airway cells models mucus obstruction and tests mannitol hydration effects.
How EDITGENE Supports mannitol transmembrane transport Research
Researchers studying mannitol transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in mannitol movement, phosphorylation coupling, or osmotic responses. EDITGENE provides the full spectrum of CRISPR cell model services to test these hypotheses rigorously.
Contact EDITGENE today to design your custom CRISPR model for mannitol transmembrane transport research.
Frequently Asked Questions About mannitol transmembrane transport
What is mannitol transmembrane transport?
Mannitol transmembrane transport (GO:0015797) is the directed movement of mannitol, a sugar alcohol derived from D-mannose, across a biological membrane.
What genes are involved in mannitol transmembrane transport?
The best-characterized gene is mtlA, which encodes the mannitol-specific Enzyme IIMtl in Escherichia coli; PTS components such as ptsH and ptsI are also involved.
How is mannitol transported in bacteria?
In Escherichia coli, mannitol is transported and phosphorylated by the phosphoenolpyruvate-dependent phosphotransferase system, with Enzyme IIMtl coupling transport to phosphorylation.
What is the function of the mannitol transporter Enzyme IIMtl?
Enzyme IIMtl binds mannitol and catalyzes its translocation across the membrane while transferring a phosphate group to mannitol.
Why is mannitol used in cystic fibrosis?
Inhaled mannitol acts as an osmotic agent to hydrate airway mucus and improve mucociliary clearance in cystic fibrosis.
Does mannitol cross the blood-brain barrier?
Mannitol is used to modulate osmotic gradients at the blood-cerebrospinal fluid barrier, and its permeability depends on barrier integrity.
What is the structure of the mannitol transporter?
The transmembrane domain of the mannitol transporter Enzyme II has been studied by electron crystallography, revealing a 5 A projection structure.
How can I study mannitol transport in the lab?
Common methods include radiolabeled mannitol uptake assays, proteoliposome reconstitution, structural biology, and CRISPR knockout of transporter genes.
What diseases are linked to mannitol transport?
Cystic fibrosis and neurological conditions involving the blood-cerebrospinal fluid barrier are linked to mannitol transport and osmotic regulation.
Can CRISPR be used to study mannitol transport genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of mannitol transport genes in bacteria and human cells.
Conclusion
GO:0015797 mannitol transmembrane transport is a fundamental biological process with deep roots in bacterial physiology and important clinical applications in cystic fibrosis and neuro-osmotic regulation. The mannitol-specific phosphotransferase system remains the best-characterized model for understanding how transport is coupled to phosphorylation. Continued research using CRISPR models and structural biology will clarify how mannitol movement can be harnessed for therapeutic and biotechnological purposes.
References
- 1. Bonadonna RC et al.. 1993. Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.. J Clin Invest 92(1):486-94 PMID: 8326013
- 2. Barry PJ et al.. 2015. New and Emerging Treatments for Cystic Fibrosis.. Drugs 75(11):1165-75 PMID: 26091951
- 3. Robillard GT et al.. 1993. Expression and characterization of a structural and functional domain of the mannitol-specific transport protein involved in the coupling of mannitol transport and phosphorylation in the phosphoenolpyruvate-dependent phosphotransferase system of Escherichia coli.. Biochemistry 32(37):9553-62 PMID: 8373762
- 4. Tildy BE et al.. 2015. Therapeutic options for hydrating airway mucus in cystic fibrosis.. Pharmacology 95(3-4):117-32 PMID: 25823699
- 5. Johanson CE et al.. 2011. The blood-cerebrospinal fluid barrier: structure and functional significance.. Methods Mol Biol 686:101-31 PMID: 21082368
- 6. Terlizzi V et al.. 2022. Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index.. Ital J Pediatr 48(1):141 PMID: 35927765
- 7. Koning RI et al.. 1999. The 5 A projection structure of the transmembrane domain of the mannitol transporter enzyme II.. J Mol Biol 287(5):845-51 PMID: 10222194
